Cardiovascular morbidity and mortality in surgically treated hyperthyroidism - a nation-wide cohort study with a long-term follow-up ObjectivePrevious studies suggest that patients with hyperthyroidism remain at an increased risk of cardiovascular morbidity even after restoring euthyroid... E Ryödi,J ...
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002 Mar 23; 359(9311): 995–1003 Article PubMed CAS Google Scholar Mochizuki S, Dahlof B, Shimizu M, et al. Valsartan in a ...
The period of the last ten years shows a continuing downward trend in mortality caused by CVD, which is more pronounced for cerebrovascular diseases, than for ischemic heart disease and especial- ly for the age from 0 to 64, but they are still the major cause of mortality and morbidity. ...
In this systematic review and meta-analysis of 23 studies involving over 15,000,000 participants, body weight variability was associated with significantly increased risk of cardiovascular morbidity and mortality. This risk remains present regardless of ethnicity or diabetic status. A previous meta-analys...
HDL functionality and cardiovascular outcome among non-dialysis chronic kidney disease patients. Cardiovascular disease remains the leading cause of morbidity and mortality in patients with chronic kidney disease (CKD). CKD profoundly affects high-dens... Kathrin,Untersteller,Sabine,... - 《Journal of...
et al. Sedentary behavior and cardiovascular morbidity and mortality: a science advisory from the American Heart Association. Circulation 134, e262–e279 (2016). Article PubMed Google Scholar Bauman, A. et al. The descriptive epidemiology of sitting. A 20-country comparison using the ...
Now days, cardiovascular disease (CVD) remains one of the leading cause of death in China, its morbidity and mortality is developing year by year. The evaluationSof regional cardiacSfunction (RCF)SinSpatientsSwithSCVD is of great importance for its diagnosis, treatment and prognosis. Strategy to ...
EvaluationoftheInstitutesprogrambalanceandprogramimpactisacontinuousprocessthatreliesonassessmentsofmorbidityandmortalityintheUnitedStatesfromcardiovascular,lung,andblooddiseases.Consideration is given to their distribution among the Foreword population; to their trends over time; and to related statistics on ...
Plasma NT-proBNP as predictor of change in functional status, cardiovascular morbidity and mortality in the oldest old: the Leiden 85-plus study. Age (Dordr) 36, 9660 (2014). Article Google Scholar Zhu, Q. et al. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide...
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Summary: Background: Blood pressure reduction achieved with 尾-blockers and diuretics is the best recorded intervention to date for prevention of ...